Proxy Votes Now

Home › Funds › Calvert › Calvert Equity Fund

Calvert Equity Fund (CEYIX) proxy voting record 2025-2026

Fund family: Calvert · Filed by Calvert Social Investment Fund (CIK 356682) · SEC series S000008719

Share classes and tickers: CEYIX (C000023765), CEYRX (C000195931), CSECX (C000023764), CSIEX (C000023762)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 552 with, 44 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 23 FOR, 22 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Calvert as a whole

The same two figures as Calvert’s manager page (93,700 ballot items across 29 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsCalvertItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)75.9%54365.8%79,586
Backed environmental and social shareholder proposals at US companiesn/a2354.2%794

Where this fund voted differently from most Calvert funds

Each ballot item this fund voted is set against the votes of the other Calvert funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Calvert funds on all 583 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 596 such votes could be given a sector.

SectorVotesAgainst managementShare
Consumer Discretionary1942110.8%
Technology1161412.1%
Industrials9511.1%
Finance8944.5%
Health Care5036.0%
Basic Materials2713.7%
Real Estate2500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4360
Audit-related480
Say-on-Pay470
Corporate Governance2416
Compensation112
Other Social Issues1111
Environment or Climate99
Capital Structure50
Shareholder Rights and Defenses42
Human Rights or Human Capital/workforce33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Visa Inc.January 27, 2026$310M184
Microsoft CorporationDecember 5, 2025$258M216
Thermo Fisher Scientific Inc.May 20, 2026$256M130
Mastercard IncorporatedJune 16, 2026$238M152
Danaher CorporationMay 5, 2026$213M140
VeriSign, Inc.May 21, 2026$197M111
Verisk Analytics, Inc.May 19, 2026$192M141
Agilent Technologies, Inc.March 18, 2026$170M70

Notable votes against management

MeetingCompanyProposalFundMgmt
January 27, 2026Visa Inc.Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal on shareholder right to act by written consent. Shareholder proposalForAgainst
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 16, 2026Mastercard IncorporatedConsideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposalForAgainst
June 16, 2026Mastercard IncorporatedConsideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposalAgainstFor
May 21, 2026VeriSign, Inc.Stockholder Proposal Regarding an Independent Chair Policy, if Properly Presented at the Meeting Shareholder proposalForAgainst
May 19, 2026Verisk Analytics, Inc.Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder proposalForAgainst
May 20, 2026S&P Global Inc.Vote on a shareholder proposal to reduce the stock ownership threshold for calling a special shareholder meeting; Shareholder proposalForAgainst
May 20, 2026S&P Global Inc.Vote on a shareholder proposal to issue a report on the Company's charitable support; Shareholder proposalAgainstFor
May 7, 2026Ecolab Inc.Vote on a stockholder proposal regarding an independent board chair policy, if properly presented at the meeting. Shareholder proposalForAgainst
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalForAgainst

Search this fund’s votes by company

599 ballot items at 45 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Calvert Equity Fund (CEYIX) voted at 45 shareholder meetings of 45 companies, on 599 ballot items in all. Where management made a recommendation, the fund followed it on 92.6% of the items and voted against it 44 times. Its most frequent area of disagreement was corporate governance (16 of its votes against management). It voted on 45 shareholder proposals. It voted FOR the board's own proposals more often than Calvert's funds as a whole (75.9% against 65.8%). It voted the same way as most Calvert funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Calvert’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.